Medtronic logo

Medtronic dividend yield (ttm)NYSE: MDT

Dividend yield (TTM)

3.05%
-0.07%-2.24%

01 November 2024

-25.61%vs 3 years high
+54.82%vs 3 years low
71.60%vs. sector
Performance
Most recent-2.2%
1 year-21.2%
3 years+51.7%
5 years+58.9%

Add series to chart

(max: 6)
company, ETF, index, featured screener or watchlist
series name

Suggested series

Dividend yield (TTM) performance

Most recent change
MDT-2.2%
GILD-1.4%
BMY+1.9%
SNY+0.8%
ELV-1.3%
1 year change
MDT-21.2%
GILD-8.1%
BMY-1.1%
SNY-6.3%
ELV+21.1%
3 years change
MDT+51.7%
GILD-20.1%
BMY+31.7%
SNY+2.1%
ELV+53.5%
5 years change
MDT+58.9%
GILD-10.0%
BMY+53.3%
SNY+0.8%
ELV+33.6%

Dividend yield (TTM) performance

MDTVRTXGILDBMYBSXSNYELV
Most recent-2.2%--1.4%+1.9%-+0.8%-1.3%
1 year-21.2%--8.1%-1.1%--6.3%+21.1%
3 years+51.7%--20.1%+31.7%-+2.1%+53.5%
5 years+58.9%--10.0%+53.3%-+0.8%+33.6%
FAQ

What is Medtronic dividend yield (ttm)?

Medtronic dividend yield (ttm) is 3.05%

What is Medtronic dividend yield (ttm) compared to its 3-years maximum value?

Medtronic dividend yield (ttm) is 74.39% of its 3-years maximum value

What is Medtronic dividend yield (ttm) compared to other companies from its sector (Healthcare)?

Medtronic dividend yield (ttm) is higher than 71.6% of the companies in the same sector (Healthcare)

How has Medtronic dividend yield (ttm) changed over the year?

Over the past year, Medtronic dividend yield (ttm) has dropped by 21.2%. During the same period, , Gilead Sciences has decreased by 8.1%, Bristol-Myers Squibb has gone down by 1.1%, Sanofi has decreased by 6.3%, Elevance Health has grown by 21.1%

How has Medtronic dividend yield (ttm) changed over the 3 years?

During the last 3 years, Medtronic dividend yield (ttm) has increased by 51.7%. Over the same period, , Gilead Sciences has decreased by 20.1%, Bristol-Myers Squibb has grown by 31.7%, Sanofi has risen by 2.1%, Elevance Health has grown by 53.5%

How has Medtronic dividend yield (ttm) changed over the 5 years?

For the past 5 years, Medtronic dividend yield (ttm) has increased by 58.9%. In the same period, , Gilead Sciences has decreased by 10.0%, Bristol-Myers Squibb has grown by 53.3%, Sanofi has risen by 0.8%, Elevance Health has grown by 33.6%